Antibody drug discovery has entered an AI‑empowered era. AI can generate thousands of antibody candidate sequences within hours — yet a sequence remains merely a hypothesis until it is synthesized, expressed, and functionally characterized. Quintara Biosciences bridges this critical divide with one unified, end‑to‑end high‑throughput pipeline.
10,000+ antibody expression per month
Abgene in 4 business
days
From $59/gene
Purified antibodies in as
fast as
2-weeks
turnaround
>95% purity, with a developability data package you can feed back into your model


Over recent years, artificial intelligence has transitioned from a novelty to a foundational design tool in antibody discovery. Generative and structure-based models generate novel CDR loops, humanize murine leads, optimize affinity, and rescue poor biophysical profiles in silico, condensing months of design effort into days.
AI, however, does not obviate experimentation — it expands experimental workload and raises demands for higher-dimensional, higher-quality data. All high-ranking virtual library candidates require synthesis, cloning, transfection, expression, purification, and characterization to generate empirical data for model retraining. As candidate numbers grow, the limiting factor shifts from computation to wet-lab capacity and data quality.
True AI‑empowered antibody discovery relies on integrated high‑throughput wet‑lab workflows for high‑quality, robust and representative experimental data. Gene synthesis, plasmid production, mammalian expression, and analytical QC run on our platforms, so an AI-generated sequence entering the pipeline on day one exits as a purified, characterized antibody with a complete data record.
Abgene is Quintara's premium high-throughput clonal gene synthesis solution, purpose-built for AI-driven antibody discovery.
Fast: When your model outputs hundreds or thousands of VH/VL variants, manual PCR, fragment assembly, and colony screening become a 4-day cycle per batch.
Flat: Predictable per-gene pricing makes cost linear with candidate count, so you can afford to synthesize the entire shortlist rather than cherry-picking.
Full-Length: 100% clonal verification option means the sequence your model designed is the sequence you test, make sure your training data stays clean.
Abgene eliminates that entirely: you submit digital sequences and receive 100% sequence-verified clonal genes ready for transfection.
Gene Length | Price/Construct | Turnaround Time |
0 - 800bp | $59 | 4 Business Day |
801 - 1,500bp | $109 | 4 Business Day |
• Default vector is pUC57 ; QuinDirect vectors (136 available) • Customer-provided vectors, a $15 vector QC fee applies to each NEW vector. $0 for cloning. Abgene is for simple genes only, and we will evaluate the sequence after receiving your request. If it is a complex gene, the Regular gene service will be another option. | ||
Quintara have mutiple vectors suitable for recombinant antibody, and here are tips for choosing vectors:
Single vs. dual cassette: pcDNA3.4, pTT5, pcDNA3.1 and pCHO1.0 are single-cassette vectors — heavy chain and light chain require two separate plasmids and an optimized co-transfection ratio. pEE12.4 carries both chains on one plasmid, eliminating the ratio optimization step.
Tagged vectors are for fragments only: Avoid Myc-His and Flag vectors for full-length IgG: a C-terminal tag can interfere with Fc conformation, and full-length antibodies are purified via Protein A affinity without any tag.
Signal peptide required: These CMV vectors generally do not carry a secretion signal. An IgG leader sequence must be added to the 5′ end of VH/VL, otherwise the antibody remains intracellular and will not appear in the supernatant.
| Vector | Promoter | Suitable Host | Suitable Antibody Type |
| pcDNA3.4 | CMV | HEK293, CHO | Full-length IgG (preferred for transient expression); scFv, Fab, VHH |
| pTT5 | CMV | HEK293 (EBNA1 system) | Full-length IgG (classic high-yield transient vector) |
| pcDNA3.1(+) | CMV | HEK293, CHO | Full-length IgG; bispecifics (paired with Zeo/Hygro vectors for co-transfection) |
| pcDNA3.1(−) | CMV | HEK293, CHO | Full-length IgG (reverse MCS; backup or control) |
| pcDNA3 | CMV | HEK293, CHO | Full-length IgG (earlier version; control) |
| pCHO1.0 | CMV | CHO | Full-length IgG (designed for CHO stable lines) |
| pEE12.4 | CMV | CHO (GS system) | Full-length IgG (dual expression cassette — HC + LC on one plasmid); bispecifics |
| pEE6.4 | CMV | CHO (GS system) | Single-chain expression; bispecifics (two plasmids, one chain each) |
| pcDNA3.1 Hygro(+) | CMV | HEK293, CHO | Full-length IgG (hygromycin selection; stable lines) |
| pcDNA3.1 Zeo(+) | CMV | HEK293, CHO | Full-length IgG (Zeocin selection; stable lines) |
| pcDNA3.1 Zeo(−) | CMV | HEK293, CHO | Full-length IgG (Zeocin selection; stable lines) |
| pCAGGS | CAG | HEK293, CHO | Full-length IgG (alternative when CMV-driven yield is low) |
| pcDNA3.1 Myc-His A | CMV | HEK293, CHO | scFv, VHH, Fab (C-terminal Myc-His tag) |
| pcDNA3.1 Myc-His B | CMV | HEK293, CHO | scFv, VHH, Fab (C-terminal Myc-His tag; reading frame B) |
| pCMV-C-Flag | CMV | HEK293, CHO | scFv, VHH, Fab (C-terminal Flag tag) |
| pCMV-N-Flag | CMV | HEK293, CHO | scFv, VHH, Fab (N-terminal Flag tag) |
| p3XFLAG-CMV-14 | CMV | HEK293, CHO | scFv, VHH, Fab (C-terminal 3×Flag tag) |
Expression throughput is ultimately capped by DNA throughput: no DNA, no transfection. Quintara's in-house plasmid preparation platform is designed to keep pace with high-throughput synthesis, delivering the quantity and quality transient expression demands. Consistent, sequence-confirmed, high-quality DNA reduces titer variance between candidates — which is the difference between comparing your designs and chasing artifacts.
Scale: Quantity guaranteed, from µg to mg quantities per construct
Continuity: Direct handoff from gene synthesis and cloning — no re-formatting, no re-verification, no shipping delays between vendors
Quality: 100% full-sequence verification available, including Nanopore whole-plasmid sequencing across insert, backbone, and junction regions
| QC Items | QC Standards (Transfection Grade) |
| Appearance | Colorless, clear, free of precipitation or foreign particles |
| Sequence Accuracy | Sequencing verification matches the order requirements |
| A260/280 | 1.8-2.0 |
| A260/230 | ≥2.0 |
| Supercoiled Content | Supercoiled ≥80% |
| Residual RNA | Not visible on agarose gel electrophoresis |
| E. coli Genomic DNA | <15% on agarose gel electrophoresis |
| Restriction Analysis | DNA bands with expected sizes detected by agarose gel electrophoresis |
| Endotoxin Level | Endotoxin ≤0.01EU/ug |
| Bio-Burden Test | No viable microorganisms in/on culture media |
Powered by high-throughput recombinant antibody expression platform, candidates are transfected into CHO or HEK293 cells using a proprietary high-expression vector, then cultured and purified at small scale for rapid, comparable readouts.
Scale: Expression scale from 1mL - 50L, from 0.2mg - 50mg.
Fast: Expression turnaround time stars from 5 business days.
Format: IgG, Fab, ScFv, VHH, di-scFV, Bi-specific antibody
IgGs, scFv, Fab, VHH, di-scFv and more
Asymmetric and symmetric Full antibody and antibody fragments
Everything downstream of the sequence. Design produces hypotheses. Quintara turns them into purified, measured antibodies at a rate that keeps your model learning rather than waiting.
Yes. Our high-throughput expression platform supports 10,000 projects per month, and Abgene gene synthesis is priced flat per gene specifically to make large candidate panels economical. Contact us to scope campaigns above standard capacity.
Abgene covers regular antibody genes. Complex or ultra-long constructs up to 200 kb are supported through Quintara Regular Gene Synthesis, delivered in as fast as 3–5 business days.
Yes. In addition to 130+ pre-validated QuinVectors, we accept customer-provided vectors (a vector QC fee applies to each new vector).
Mammalian transient transfection in CHO or HEK293 cells, using Quintara's proprietary high-expression vector — the system of choice for preserving antibody folding, assembly, and PTMs.
Yes. Beyond expression process and routine quality QC data, we also offer customizable developability analytics tailored to the requirements of your AI model. Please share your assay requirements with us for further discussion.

High-throughput platform delivering purified antibodies from micrograms to milligrams.
Discover moreQuintara offers design, expression, and purification of BsAbs for therapeutics.
Discover more
Precision and custom gene synthesis from Quintara Biosciences for your research needs.
Discover more